

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.11196675 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11196675 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99916065 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49450836 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.48009851 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31059338 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22888599 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19300904 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13920103 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.99911404 |
| 11 | positive thymic T cell selection (GO:0045059) | 3.94084297 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92853732 |
| 13 | leukocyte aggregation (GO:0070486) | 3.92274547 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86888003 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.86888003 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86888003 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86888003 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86888003 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.86888003 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.84180782 |
| 21 | thymic T cell selection (GO:0045061) | 3.82586333 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80121064 |
| 23 | mannose metabolic process (GO:0006013) | 3.75193217 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.73506687 |
| 25 | detection of bacterium (GO:0016045) | 3.71297828 |
| 26 | negative T cell selection (GO:0043383) | 3.70198637 |
| 27 | detection of other organism (GO:0098543) | 3.65708160 |
| 28 | response to peptidoglycan (GO:0032494) | 3.64078003 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.64057866 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57422473 |
| 31 | T cell selection (GO:0045058) | 3.53357401 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.45512131 |
| 33 | germinal center formation (GO:0002467) | 3.45304820 |
| 34 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.44162062 |
| 35 | NIK/NF-kappaB signaling (GO:0038061) | 3.42714233 |
| 36 | positive T cell selection (GO:0043368) | 3.40111418 |
| 37 | response to interleukin-15 (GO:0070672) | 3.32780280 |
| 38 | tolerance induction (GO:0002507) | 3.31463719 |
| 39 | histone H3-K36 demethylation (GO:0070544) | 3.29636117 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 3.27578760 |
| 41 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19291451 |
| 42 | regulation of histone H3-K27 methylation (GO:0061085) | 3.15379907 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 3.05938465 |
| 44 | T cell migration (GO:0072678) | 3.04671040 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02573177 |
| 46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01929312 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99960982 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 2.97419879 |
| 49 | cellular extravasation (GO:0045123) | 2.96730720 |
| 50 | negative regulation of innate immune response (GO:0045824) | 2.92808653 |
| 51 | response to type I interferon (GO:0034340) | 2.92683110 |
| 52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91974636 |
| 53 | cellular response to type I interferon (GO:0071357) | 2.91249541 |
| 54 | type I interferon signaling pathway (GO:0060337) | 2.91249541 |
| 55 | detection of external biotic stimulus (GO:0098581) | 2.90384285 |
| 56 | response to host (GO:0075136) | 2.86578511 |
| 57 | response to host defenses (GO:0052200) | 2.86578511 |
| 58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86578511 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85740582 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 2.84427562 |
| 61 | response to host immune response (GO:0052572) | 2.82936136 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82936136 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 2.82393445 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.82369137 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 2.81718675 |
| 66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72476560 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 2.72416358 |
| 68 | positive regulation of histone deacetylation (GO:0031065) | 2.70571319 |
| 69 | modulation by virus of host process (GO:0019054) | 2.68952017 |
| 70 | defense response to protozoan (GO:0042832) | 2.67730422 |
| 71 | positive regulation of Rap GTPase activity (GO:0032854) | 2.66392914 |
| 72 | regulation of ARF GTPase activity (GO:0032312) | 2.66328391 |
| 73 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63735710 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 2.63441087 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.62336566 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60985909 |
| 77 | positive regulation of protein deacetylation (GO:0090312) | 2.59640408 |
| 78 | modulation by symbiont of host cellular process (GO:0044068) | 2.59504338 |
| 79 | embryonic process involved in female pregnancy (GO:0060136) | 2.58993827 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 2.57141434 |
| 81 | B cell homeostasis (GO:0001782) | 2.56396581 |
| 82 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55918374 |
| 83 | response to protozoan (GO:0001562) | 2.55688314 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55651938 |
| 85 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.54804487 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54647456 |
| 87 | signal complex assembly (GO:0007172) | 2.54309557 |
| 88 | negative regulation of interleukin-6 production (GO:0032715) | 2.53526556 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53164230 |
| 90 | regulation of granulocyte differentiation (GO:0030852) | 2.52829141 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.51812265 |
| 92 | T-helper cell differentiation (GO:0042093) | 2.51289747 |
| 93 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.51289747 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.50301427 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.50197907 |
| 96 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49339704 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48846841 |
| 98 | histone H4 deacetylation (GO:0070933) | 2.48731978 |
| 99 | neutrophil activation (GO:0042119) | 2.48607136 |
| 100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.47351978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.53893940 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.44480161 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.10570580 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71355811 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.68774295 |
| 6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.67134673 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.64096396 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.48214709 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48060150 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.46297474 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.46066679 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40755974 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39309564 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38163773 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31415023 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28510155 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26595744 |
| 18 | MAF_26560356_Chip-Seq_TH2_Human | 2.18746683 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18104381 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.13222365 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06998822 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05281990 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03903072 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.98450351 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94674557 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91206855 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91169868 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90582358 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85154639 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80757622 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.80591537 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78508220 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76261529 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75329554 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.72851753 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.72124390 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.71418336 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69286846 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69033709 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.66388723 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.64488014 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55113712 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54295442 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.53622762 |
| 45 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.52938288 |
| 46 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52463611 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46769445 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43897568 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43599707 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42526817 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42003386 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40911528 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39747319 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37898329 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37685086 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37400211 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36794132 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36786440 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36242341 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35688309 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.31909270 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31722838 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31223564 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29082450 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25039267 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24454368 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24030952 |
| 68 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21164727 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21127050 |
| 70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20096079 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19676534 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18585346 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16557316 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16539255 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15992630 |
| 76 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15387058 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13761840 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13095419 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13079846 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11440124 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11122051 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10377416 |
| 83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10146824 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09784323 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09600341 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07927705 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07686183 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07656765 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06162762 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05771512 |
| 91 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05220601 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04333254 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03413876 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02160795 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01423980 |
| 96 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01397573 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00295250 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98908501 |
| 99 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.98844167 |
| 100 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.98724736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.88949785 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.22191037 |
| 3 | MP0003303_peritoneal_inflammation | 2.96693163 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.72406304 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.55749102 |
| 6 | MP0001800_abnormal_humoral_immune | 2.52848017 |
| 7 | MP0000685_abnormal_immune_system | 2.52334649 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.51168838 |
| 9 | MP0008260_abnormal_autophagy | 2.50673479 |
| 10 | MP0003724_increased_susceptibility_to | 2.45325927 |
| 11 | MP0001790_abnormal_immune_system | 2.42154974 |
| 12 | MP0005387_immune_system_phenotype | 2.42154974 |
| 13 | MP0005451_abnormal_body_composition | 2.38926216 |
| 14 | MP0009278_abnormal_bone_marrow | 2.34764785 |
| 15 | MP0005671_abnormal_response_to | 2.30350585 |
| 16 | MP0002419_abnormal_innate_immunity | 2.29855698 |
| 17 | MP0002723_abnormal_immune_serum | 2.27543392 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.27445137 |
| 19 | MP0005025_abnormal_response_to | 2.27303279 |
| 20 | MP0004947_skin_inflammation | 2.26642539 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.20292590 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.16048446 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.14122451 |
| 24 | MP0001819_abnormal_immune_cell | 2.13882351 |
| 25 | MP0009840_abnormal_foam_cell | 2.06135035 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.01821399 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.99063640 |
| 28 | MP0002398_abnormal_bone_marrow | 1.98683338 |
| 29 | MP0001873_stomach_inflammation | 1.91279724 |
| 30 | MP0002405_respiratory_system_inflammati | 1.89569997 |
| 31 | MP0004381_abnormal_hair_follicle | 1.83732585 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.79192022 |
| 33 | MP0000716_abnormal_immune_system | 1.78393180 |
| 34 | MP0009785_altered_susceptibility_to | 1.78220645 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.70853300 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.69707793 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.69232653 |
| 38 | MP0005310_abnormal_salivary_gland | 1.64966625 |
| 39 | MP0002722_abnormal_immune_system | 1.61689238 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.60053710 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.59262589 |
| 42 | MP0006082_CNS_inflammation | 1.52334490 |
| 43 | MP0002429_abnormal_blood_cell | 1.50113460 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.48237365 |
| 45 | MP0004510_myositis | 1.44783181 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.44738607 |
| 47 | MP0003828_pulmonary_edema | 1.43463958 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.42113566 |
| 49 | MP0002933_joint_inflammation | 1.40821637 |
| 50 | MP0002009_preneoplasia | 1.40021017 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.38298618 |
| 52 | MP0000858_altered_metastatic_potential | 1.35275558 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.35133146 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.33516496 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.32830473 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.32359592 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.29677955 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.27495461 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.27495461 |
| 60 | MP0001851_eye_inflammation | 1.19542697 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.19142092 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.18380249 |
| 63 | MP0008469_abnormal_protein_level | 1.16985473 |
| 64 | MP0003091_abnormal_cell_migration | 1.14812050 |
| 65 | MP0003866_abnormal_defecation | 1.11566518 |
| 66 | MP0001853_heart_inflammation | 1.08997535 |
| 67 | MP0001849_ear_inflammation | 1.08494377 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.01101974 |
| 69 | MP0002132_abnormal_respiratory_system | 1.00565401 |
| 70 | MP0005409_darkened_coat_color | 1.00508762 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.00257546 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.98950454 |
| 73 | MP0003045_fibrosis | 0.92073322 |
| 74 | MP0005666_abnormal_adipose_tissue | 0.88355957 |
| 75 | MP0002796_impaired_skin_barrier | 0.86939337 |
| 76 | MP0002006_tumorigenesis | 0.85289877 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.83646417 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.82131488 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.81927161 |
| 80 | MP0000490_abnormal_crypts_of | 0.80725218 |
| 81 | MP0005083_abnormal_biliary_tract | 0.80490570 |
| 82 | MP0002254_reproductive_system_inflammat | 0.80137800 |
| 83 | MP0009115_abnormal_fat_cell | 0.80118030 |
| 84 | MP0009931_abnormal_skin_appearance | 0.77769679 |
| 85 | MP0005621_abnormal_cell_physiology | 0.75817580 |
| 86 | MP0009764_decreased_sensitivity_to | 0.75727325 |
| 87 | MP0005390_skeleton_phenotype | 0.75518522 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.74253579 |
| 89 | MP0003075_altered_response_to | 0.73665185 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.73624546 |
| 91 | MP0003448_altered_tumor_morphology | 0.72299729 |
| 92 | MP0000604_amyloidosis | 0.68570454 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.66271957 |
| 94 | MP0002970_abnormal_white_adipose | 0.65948658 |
| 95 | MP0008874_decreased_physiological_sensi | 0.64659353 |
| 96 | MP0000249_abnormal_blood_vessel | 0.64586124 |
| 97 | MP0003329_amyloid_beta_deposits | 0.63141619 |
| 98 | MP0004130_abnormal_muscle_cell | 0.62699069 |
| 99 | MP0003795_abnormal_bone_structure | 0.62530810 |
| 100 | MP0005166_decreased_susceptibility_to | 0.62339304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.17065871 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.82149555 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.81182075 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.47593661 |
| 5 | Myositis (HP:0100614) | 3.46435479 |
| 6 | Increased IgE level (HP:0003212) | 3.45358098 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.38203331 |
| 8 | Colitis (HP:0002583) | 3.13937540 |
| 9 | Broad face (HP:0000283) | 3.12918332 |
| 10 | Pustule (HP:0200039) | 3.10594799 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.07520433 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.99725890 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 2.99222727 |
| 14 | Orchitis (HP:0100796) | 2.97342076 |
| 15 | Stomatitis (HP:0010280) | 2.96332218 |
| 16 | Abnormality of the fingertips (HP:0001211) | 2.91414480 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.91193486 |
| 18 | Cellulitis (HP:0100658) | 2.85612919 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84878780 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84878780 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.82971644 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 2.82668279 |
| 23 | Inflammation of the large intestine (HP:0002037) | 2.82400025 |
| 24 | Meningitis (HP:0001287) | 2.79036250 |
| 25 | Recurrent viral infections (HP:0004429) | 2.77433199 |
| 26 | Optic neuritis (HP:0100653) | 2.76507024 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.76507024 |
| 28 | Recurrent skin infections (HP:0001581) | 2.75651190 |
| 29 | Obstructive lung disease (HP:0006536) | 2.68479984 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68479984 |
| 31 | Gingivitis (HP:0000230) | 2.66200626 |
| 32 | Gastrointestinal stroma tumor (HP:0100723) | 2.64359395 |
| 33 | Thin bony cortex (HP:0002753) | 2.63506186 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60669321 |
| 35 | Vasculitis (HP:0002633) | 2.57786633 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.55371429 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41334859 |
| 38 | Dysostosis multiplex (HP:0000943) | 2.37301111 |
| 39 | Loss of speech (HP:0002371) | 2.34611121 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.33821956 |
| 41 | T lymphocytopenia (HP:0005403) | 2.31568255 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29039401 |
| 43 | Slow saccadic eye movements (HP:0000514) | 2.28913927 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.28884971 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.27049856 |
| 46 | Lymphopenia (HP:0001888) | 2.25462310 |
| 47 | Chest pain (HP:0100749) | 2.23397664 |
| 48 | Hypochromic anemia (HP:0001931) | 2.22048036 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21666923 |
| 50 | Emphysema (HP:0002097) | 2.16779126 |
| 51 | Abnormality of T cells (HP:0002843) | 2.15728995 |
| 52 | Verrucae (HP:0200043) | 2.14201137 |
| 53 | Papilloma (HP:0012740) | 2.14201137 |
| 54 | Epistaxis (HP:0000421) | 2.11228837 |
| 55 | Granulocytopenia (HP:0001913) | 2.09495184 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09418263 |
| 57 | Encephalitis (HP:0002383) | 2.07744880 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.07296056 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.06751395 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.05175337 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04280814 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04280814 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04280814 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.02686164 |
| 65 | Hemoptysis (HP:0002105) | 2.02403389 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.01956992 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.00841635 |
| 68 | Pulmonary infiltrates (HP:0002113) | 1.99065555 |
| 69 | Severe visual impairment (HP:0001141) | 1.96768248 |
| 70 | Easy fatigability (HP:0003388) | 1.94356475 |
| 71 | Urticaria (HP:0001025) | 1.93992504 |
| 72 | Basal cell carcinoma (HP:0002671) | 1.93642548 |
| 73 | Keratoconjunctivitis (HP:0001096) | 1.93572971 |
| 74 | Fatigue (HP:0012378) | 1.92881244 |
| 75 | Nuclear cataract (HP:0100018) | 1.92226807 |
| 76 | Abnormality of the columella (HP:0009929) | 1.91398073 |
| 77 | Osteomyelitis (HP:0002754) | 1.91020035 |
| 78 | Mucopolysacchariduria (HP:0008155) | 1.89579579 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89579579 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 1.86279402 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 1.84565112 |
| 82 | Restrictive lung disease (HP:0002091) | 1.84114439 |
| 83 | Increased serum ferritin (HP:0003281) | 1.82974936 |
| 84 | Seborrheic dermatitis (HP:0001051) | 1.78710685 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78516678 |
| 86 | Leukocytosis (HP:0001974) | 1.77528688 |
| 87 | Long palpebral fissure (HP:0000637) | 1.73320478 |
| 88 | Arterial thrombosis (HP:0004420) | 1.72856162 |
| 89 | Increased connective tissue (HP:0009025) | 1.72591759 |
| 90 | Acute hepatic failure (HP:0006554) | 1.72274345 |
| 91 | Sepsis (HP:0100806) | 1.71357326 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 1.70130998 |
| 93 | Hypertensive crisis (HP:0100735) | 1.69991825 |
| 94 | Malnutrition (HP:0004395) | 1.68730686 |
| 95 | Deep palmar crease (HP:0006191) | 1.68307244 |
| 96 | Viral hepatitis (HP:0006562) | 1.67927753 |
| 97 | J-shaped sella turcica (HP:0002680) | 1.67332406 |
| 98 | Papilledema (HP:0001085) | 1.66744018 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 1.65852428 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.65620987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.53621100 |
| 2 | PRPF4B | 3.41882332 |
| 3 | TRIB3 | 3.36353682 |
| 4 | RIPK4 | 2.62562938 |
| 5 | CDK12 | 2.61117478 |
| 6 | ERN1 | 2.57279217 |
| 7 | SMG1 | 2.24749873 |
| 8 | SIK1 | 2.23635199 |
| 9 | MAP2K3 | 2.23283459 |
| 10 | IRAK4 | 2.21332286 |
| 11 | TYK2 | 1.93368115 |
| 12 | MAP3K14 | 1.82985366 |
| 13 | ZAP70 | 1.81416615 |
| 14 | BLK | 1.81009132 |
| 15 | GRK6 | 1.80574476 |
| 16 | IRAK3 | 1.79843896 |
| 17 | TNK2 | 1.76018136 |
| 18 | MAP3K13 | 1.74109376 |
| 19 | TBK1 | 1.72579075 |
| 20 | SIK2 | 1.68676488 |
| 21 | ICK | 1.67743640 |
| 22 | EPHB1 | 1.63263454 |
| 23 | EEF2K | 1.58975452 |
| 24 | SIK3 | 1.58187461 |
| 25 | TAOK1 | 1.47734119 |
| 26 | FGFR4 | 1.46063639 |
| 27 | FES | 1.45258926 |
| 28 | MARK2 | 1.41752465 |
| 29 | IKBKE | 1.41053079 |
| 30 | MAP3K10 | 1.40146271 |
| 31 | TXK | 1.37924537 |
| 32 | JAK3 | 1.37408471 |
| 33 | CSK | 1.36102740 |
| 34 | JAK1 | 1.23170327 |
| 35 | MAP3K1 | 1.22508908 |
| 36 | MAP3K3 | 1.22235515 |
| 37 | BTK | 1.21039576 |
| 38 | MAP3K11 | 1.21036574 |
| 39 | CDC42BPA | 1.18522658 |
| 40 | KSR2 | 1.17221971 |
| 41 | HCK | 1.16327006 |
| 42 | BRD4 | 1.15291191 |
| 43 | IKBKB | 1.10423849 |
| 44 | MAP3K7 | 1.09549045 |
| 45 | MAPK11 | 1.09157278 |
| 46 | PDPK1 | 1.08043113 |
| 47 | TAOK2 | 1.05512639 |
| 48 | PDK1 | 1.05287997 |
| 49 | PRKD2 | 1.05286447 |
| 50 | MAP2K6 | 1.05183193 |
| 51 | CDK4 | 0.96856948 |
| 52 | SYK | 0.94624554 |
| 53 | TESK2 | 0.89298065 |
| 54 | LCK | 0.85505894 |
| 55 | MAPK12 | 0.85143976 |
| 56 | HIPK2 | 0.84970134 |
| 57 | STK38 | 0.83421757 |
| 58 | RIPK1 | 0.82924980 |
| 59 | ITK | 0.81334357 |
| 60 | CSF1R | 0.80498706 |
| 61 | IRAK2 | 0.79704451 |
| 62 | MTOR | 0.76775537 |
| 63 | FGFR3 | 0.75398253 |
| 64 | MARK3 | 0.74080101 |
| 65 | CHUK | 0.74071776 |
| 66 | TTN | 0.73958615 |
| 67 | PKN2 | 0.73536686 |
| 68 | MAP2K2 | 0.73135772 |
| 69 | CAMK1D | 0.72930519 |
| 70 | LYN | 0.71113102 |
| 71 | MELK | 0.69351532 |
| 72 | RPS6KL1 | 0.69330626 |
| 73 | RPS6KC1 | 0.69330626 |
| 74 | RPS6KA2 | 0.68759823 |
| 75 | FGR | 0.68039820 |
| 76 | PTK6 | 0.67173137 |
| 77 | JAK2 | 0.66675269 |
| 78 | BMX | 0.64406299 |
| 79 | MAPK7 | 0.61128555 |
| 80 | IRAK1 | 0.59731321 |
| 81 | CAMKK1 | 0.57657842 |
| 82 | RPS6KA6 | 0.53861185 |
| 83 | STK10 | 0.52814568 |
| 84 | TYRO3 | 0.49684624 |
| 85 | PIM1 | 0.49615245 |
| 86 | RET | 0.48817154 |
| 87 | SGK3 | 0.48004650 |
| 88 | TAOK3 | 0.46466570 |
| 89 | CDK6 | 0.46350255 |
| 90 | YES1 | 0.45183599 |
| 91 | KIT | 0.44629024 |
| 92 | RAF1 | 0.41402585 |
| 93 | DYRK1B | 0.41067755 |
| 94 | PRKD3 | 0.40257592 |
| 95 | NME2 | 0.39589541 |
| 96 | RPS6KA1 | 0.38908815 |
| 97 | MAP3K6 | 0.35951108 |
| 98 | NEK6 | 0.35050093 |
| 99 | MATK | 0.34335081 |
| 100 | MAPKAPK2 | 0.33786301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41430857 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28776597 |
| 3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.28692847 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28550191 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07454605 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.00858870 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91703300 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81575739 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.75579684 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75550842 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75530476 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73863684 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67447726 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63807490 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63591473 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.58452594 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.53304347 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.52029901 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51880957 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50078310 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49687206 |
| 22 | Hepatitis B_Homo sapiens_hsa05161 | 1.45032109 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44733962 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43826011 |
| 25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.43561630 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.40903349 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39555720 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35903622 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35448699 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30086643 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29784537 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22072027 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.22057809 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21612466 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21556566 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15702803 |
| 37 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15102694 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14164968 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13111082 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12906514 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11561064 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.08091745 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07315233 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06268910 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05519358 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05245449 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03802945 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03307914 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02713183 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.96790509 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96597553 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96419949 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95078872 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.94923029 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94876729 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94382302 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93115070 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.92644959 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92332077 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92124702 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90899097 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.90614014 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89445700 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.88749756 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88143117 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88035698 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85752417 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85434541 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.85002883 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84945235 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.84931876 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84581646 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.82342435 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81189418 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80213124 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.79284961 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77647560 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77554148 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.74139175 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73846109 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72189860 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.71386109 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69004700 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66622510 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66329657 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65260170 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63604505 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61273217 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60783420 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60094218 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59758318 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.59741860 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59348744 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58126938 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56147726 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54974012 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53045743 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52197870 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.51670651 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50842388 |

